Birth of Parthenote Mice Directly from Parthenogenetic Embryonic Stem Cells.
Mammalian parthenogenetic embryos are not viable and die due to defects in placental development and genomic imprinting. Parthenogenetic embryonic stem cells (pESC) derived from parthenogenetic embryos might advance regenerative medicine by avoiding immuno-rejection. However, previous reports suggest that pESC may fail to differentiate and contribute to some organs in chimeras, including muscle and pancreas, and it remains unclear whether pESC themselves can form all tissue types in the body. We found that derivation of pESC is more efficient than of fESC, in association with reduced MAPK signaling in parthenogenetic embryos and their ICM outgrowth. Furthermore, in vitro culture modifies the expression of imprinted genes in pESC and these cells, being functionally indistinguishable from fertilized embryo-derived ESCs, can contribute to all organs in chimeras. Even more surprisingly, our study shows that live parthenote pups were produced from pESC via tetraploid embryo complementation, which contributes to placenta development. This is the first demonstration that pESCs are capable of full-term development, and can differentiate into all cell types and functional organs in the body.